Could a shower gel plus lotion beat lotion alone for dry, itchy skin?

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age: 18-70 years old * Gender: both * Sensitive skin and 30% to 50% with atopic tendency (scored 8-12) * With dry or very dry skin on the body * With presence of itching due to different origins: contact/friction with fabrics, hard water, atopic tendency, dry skin, etc. Exclusion Criteria: * cutaneous marks on the experimental areas, which could interfere with the assessment of skin reactions (pigmentation troubles, scar elements, over-developed pilosity, ephelides and naevi in too great quantity, sunburn), * allergy or reactivity to products of the same category than the tested one, * with history of malignant melanomas (Dubreullh melanosis…) * unbalanced hormonal treatment, * forecast of initiation of an hormonal treatment or change of the usual hormonal treatment during the study or 3 months before the starting of the study, * forecast of intensive sun or UVA exposure (UV lamps) during the test period, * breast-feeding or pregnancy, * treatment with Vitamin A acid or its derivatives stopped less than 3 months before the beginning of the study, * treatment with anti-stretch, firming, slimming or anti-cellulite products stopped less than 3 months before the beginning of the study, * diet stopped less than 3 months before the beginning of the study, * drugs likely to produce an increase or reduction in body weight, * under anti-cellulite treatment: mesotherapy, electrotherapy, ionisation, ultrasonotherapy, relaxation, acupuncture, hydrotherapy, lymphatic drainage, massage, sauna,…, * neither antibiotic, anti-allergic, anti-inflammatory treatment nor treatment with patent medicines containing Vitamin A acid or its derivatives before and during the study (if therapeutic requirement: exclusion foreseen), * systemic disorders: Cardiovascular, pulmonary, digestive, neurologic, psychiatric, genital, urinary, haematological, endocrine * individuals who have undergone a bilateral mastectomy with lymph node removal, a unilateral mastectomy with lymph node removal within the last year, or a bilateral axillary lymph node removal, * individuals with a history of immune deficiency or auto-immune disease, treated for malignancy within 6 months prior to enrollment or who are currently under treatment for asthma or diabetes, * forecast of vaccination during the test period or last vaccination within 3 weeks before the study